Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 62011TO0243

    Rješenje Općeg suda (sedmo vijeće) od 9. studenog 2011.
    Glaxo Group Ltd protiv Ureda za usklađivanje na unutarnjem tržištu (žigovi i dizajni) (OHIM).
    Žig Zajednice - Nedopuštenost.
    Predmet T-243/11.

    ECLI identifier: ECLI:EU:T:2011:649





    Order of the General Court (Seventh Chamber) of 9 November 2011 – Glaxo Group v OHIM – Farmodiética (ADVANCE)

    (Case T-243/11)

    Community trade mark – Applicant represented by a lawyer who is a not a third party – Inadmissibility

    Procedure – Application initiating proceedings – Formal requirements – Conditions relating to a signatory – Third party capacity in relation to the parties – Application signed by an internal lawyer of a group company – Inadmissibility (Statute of the Court of Justice, Arts 19 and 21, first para.; Rules of Procedure of the General Court, Art. 43(1), first para.) (see paras 13, 15, 18-19)

    Re:

    ACTION brought against the decision of the Fourth Board of Appeal of OHIM of 25 February 2011 (Case R 665/2010-4), concerning opposition proceedings between Farmodiética – Cosmética, Dietética e Produtos Farmacêuticos, L da and Glaxo Group Ltd.

    Operative part

    1.

    The action is dismissed as inadmissible.

    2.

    Glaxo Group Ltd is ordered pay the costs.

    Top